A novel method for distinguishing between dsDNA and ssRNA virus infections

Journal of Clinical Virology

Volumn 43, Issue 1, 2008, Pages 49-55

  Nuutila, Jari ^a   Hohenthal, Ulla ^b   Laitinen, Iina ^b   Kotilainen, Pirkko ^b   Rajamäki, Allan ^c   Nikoskelainen, Jukka ^b   Lilius, Esa Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Mehilainen Oy   (Finland)

Author keywords

Bacterial infections; Differential diagnosis; Infectious diseases; Monocyte Fc RI (CD64); Neutrophil Fc RI (CD64); Viral infections

Indexed keywords

C REACTIVE PROTEIN; CD64 ANTIGEN; DOUBLE STRANDED DNA; SINGLE STRANDED RNA;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DNA VIRUS; ERYTHROCYTE SEDIMENTATION RATE; FLOW CYTOMETRY; HOSPITAL PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA VIRUS; RNA VIRUS INFECTION; VIRUS DETECTION; VIRUS INFECTION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA VIRUS INFECTIONS; FEVER; FLOW CYTOMETRY; HUMANS; MONOCYTES; NEUTROPHILS; RECEPTORS, IGG; RNA VIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY;

EID: 49749114852     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.04.004     Document Type: Article

References (15)

1. Cunha B.A., Eisenstein L.E., Dillard T., and Krol V. Herpes simplex virus (HSV) pneumonia in a heart transplant: diagnosis and therapy. Heart Lung 36 (2007) 72-78
2. Ferrari A., Luppi M., Potenza L., Riva G., Morselli M., Imovilli A., et al. Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. Leukemia 9 (2005) 2019-2021
3. Grimes D.A., and Schulz K.F. Refining clinical diagnosis with likelihood ratios. Lancet 365 (2005) 1500-1505
4. Gross G., Schofer H., Wassilew S., Friese K., Timm A., Guthoff R., et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 26 277-289 (2003) 291-293 (Discussion)
5. Hewlett G., Hallenberger S., and Rubsamen-Waigmann H. Antivirals against DNA viruses (hepatitis B and the herpes viruses). Curr Opin Pharmacol 4 (2004) 453-464
6. Hohenthal U., Nuutila J., Lilius E.M., Laitinen I., Nikoskelainen J., and Kotilainen P. Measurement of complement receptor 1 on neutrophils in bacterial and viral pneumonia. BMC Infect Dis 6 (2006) 11
7. Jefferson T., Demicheli V., Rivetti D., Jones M., Di Pietrantonj C., and Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 367 (2006) 303-313
8. Leino L., Sorvajarvi K., Katajisto J., Laine M., Lilius E.M., Pelliniemi T.T., et al. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin Exp Immunol 107 (1997) 37-43
9. Logan S.A., and MacMahon E. Viral meningitis. BMJ 336 (2008) 36-40
10. Moayyedi P., and Axon A.T. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 94 (1999) 3122-3125
11. Nuutila J., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., Nikoskelainen J., et al. Quantitative analysis of complement receptors, CR1 (CD35) and CR3 (CD11b), on neutrophils improves distinction between bacterial and viral infections in febrile patients: comparison with standard clinical laboratory data. J Immunol Methods 315 (2006) 191-201
12. Nuutila J., and Lilius E.M. Distinction between bacterial and viral infections. Curr Opin Infect Dis 20 (2007) 304-310
13. Nuutila J., Hohenthal U., Laitinen I., Kotilainen P., Rajamaki A., Nikoskelainen J., et al. Simultaneous quantitative analysis of FcgammaRI (CD64) expression on neutrophils and monocytes: a new, improved way to detect infections. J Immunol Methods 328 (2007) 189-200
14. Tarp B., Jensen-Fangel S., Dahl R., and Obel N. Herpesvirus type 1-8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals. Eur Respir J 18 (2001) 146-150
15. Wainberg M.A. The emergence of HIV resistance and new antiretrovirals: are we winning?. Drug Resist Update 7 (2004) 163-167